PhRMA Report lists 73 New Investigational Medicines For Breast Cancer Treatment

PhRMA Report lists 73 New Investigational Medicines For Breast Cancer Treatment
06PhrmaAccording to a recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA), biopharmaceutical research companies in the United States are currently developing almost 800 new therapeutic options for cancer, 73 of which are specific for breast cancer treatment. "In recent decades, we have seen great progress in developing effective cancer treatments that help extend lives, improve quality of life and increase productivity," PhRMA President and CEO John J. Castellani said in a PR Newswire press release. "Continued research has expanded our knowledge of how cancer develops and how to target medicines for specific cancer types, which has resulted in more effective therapies for patients." According to the new report, biopharmaceutical research has put an intense effort in developing innovative and alternative ways to fight cancer. Moreover, biomedical research is also focusing on new ways to use existing medicines, either as single agents or in combination with other types of therapies. So far, of the total 771 new medicines and vaccines undergoing clinical trials or waiting an approval by the U.S. Food an
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.